Posted by Michael Wonder on 18 Jan 2016
Impax receives FDA approval of Emverm (mebendazole) 100 mg chewable tablets
15 January 2016 - Emverm provides a new option for patients with pinworm, whipworm, roundworm and hookworm in single or mixed infections.
For more details, go to: http://investors.impaxlabs.com/Media-Center/Press-Releases/Press-Release-Details/2016/Impax-Receives-Approval-of-EMVERM-mebendazole-Chewable-Tablets-100-mg/default.aspx
